authors
- Khan, Abdullah M
- Ashley E. Rosko, MD
- Dvorak, Kiatlyn
- Zhao, Qiuhong
- Bumma, Naresh
- Cottini, Francesca
- Devarakonda, Srinivas
- Umyarova, Elvira
- Sharma, Nidhi
- Benson, Don
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma.
- Overview
- Identity
- Additional Document Info
- View All